Background And Aim Of The Study: Beating heart aortic valve (re)placement without thoracotomy would be a desirable therapeutic strategy. In the present study, the feasibility of an endovascular aortic valve (re)placement was evaluated in an animal model.
Methods: A self-expandable stent-valve and two different non-obstructive delivery devices were designed. Initially, the stent-valve was temporarily placed via surgically dissected carotid and subclavian arteries. After retrieval of the stent-valve, an endovascular resection of the native aortic valve was performed, followed by definitive stent-valve implantation. All procedures were performed under echocardiographic guidance.
Results: Non-aortic vascular access was obtained in all animals. Via the carotid artery, the stent-valve was first placed into, and then retrieved from, the subcoronary position. Next, the native aortic valve was resected endovascularly, resulting in at least partial resection in all cases. The final step, definitive stent-valve implantation, was successful in all animals. The biological heart valve became functional after only a partial release of the stent. All animals remained hemodynamically stable after definitive implantation. Correct subcoronary position of the stent-valve was confirmed in a post-mortem examination. There was marked thrombus formation.
Conclusion: The study results proved the feasibility of: (i) reversible stent-valve placement with a nonobstructive technique in the beating heart; and (ii) partial endovascular resection of the aortic valve, with both procedures achieved via non-aortic access.
Download full-text PDF |
Source |
---|
Int J Cardiovasc Imaging
January 2025
Cardiology Division, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210st, Bronx, NY, USA.
Computed tomography (CT)-derived Epicardial Adipose Tissue (EAT) is linked to cardiovascular disease outcomes. However, its role in patients undergoing Transcatheter Aortic Valve Replacement (TAVR) and the interplay with aortic stenosis (AS) cardiac damage (CD) remains unexplored. We aim to investigate the relationship between EAT characteristics, AS CD, and all-cause mortality.
View Article and Find Full Text PDFHeart Lung Circ
January 2025
Edwards Lifesciences ANZ, Sydney, NSW, Australia.
Background: Untreated severe heart valve disease (HVD) is associated with premature mortality. Research shows low population awareness of when to seek assessment and low focus on cardiac auscultation by physicians in primary care settings. We studied contemporary public knowledge of HVD and assessment by their general practitioner (GP) in Australia.
View Article and Find Full Text PDFCan J Cardiol
January 2025
Division of Cardiac Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB. Electronic address:
The volume of transcatheter aortic valve implantation (TAVI) for treatment of isolated aortic stenosis has far surpassed surgical aortic valve replacement (SAVR). There has been a consequent increase in TAVI explantation, now the fastest growing cardiac surgical procedure. Transcatheter heart valve explantation can be technically complex, with higher perioperative morbidity and mortality than routine SAVR or valve-in-valve TAVI.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
January 2025
Department of Surgery, Division of Vascular Surgery, University of Maryland School of Medicine.
Objective: We present our experience with endovascular Bentall procedure (Endo-Bentall) using a modular valve conduit (Endo-Bentall) in high-risk patients with aortic root pathologies.
Methods: The physician constructed Endo-Bentall device is composed of a self-expanding transcatheter aortic valve (TAVR), aortic endovascular stent graft (TEVAR), and two wire-reinforced fenestrations for coronary artery stenting. The TAVR valve is sutured into an appropriately sized TEVAR graft.
J Thorac Cardiovasc Surg
January 2025
University of Maryland School of Medicine, Division of Cardiothoracic Surgery. Electronic address:
Objective: Over 30% of patients presenting with acute type A aortic dissection (ATAAD) are considered high - risk or inoperable. This study aims to investigate the early and mid-term outcomes of complex endovascular aortic repair of aortic root, ascending aorta, and aortic arch among patients with ATAAD.
Methods: From January 2018 to January 2023, 29 patients who were considered high risk for open operation underwent endovascular aortic repair.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!